24 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
29 Sep 21
Departure of Directors or Certain Officers
5:07pm
2018.
“We will greatly miss Sam and his tremendous support for Coherus. Long before joining the Coherus board, he lived a mission of providing greater … Coherus BioSciences
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
2 Feb 21
Entry into a Material Definitive Agreement
8:45am
research capabilities, and we are excited to collaborate with them as we build on our success in oncology with biosimilars and broaden our mission … .
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
13 Oct 21
Departure of Directors or Certain Officers
5:01pm
Harvard Law School.
About Coherus BioSciences
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
6 Aug 20
Coherus BioSciences Appoints Kimberly Tzoumakas, J.D. to Board of Directors
4:19pm
looking forward to working with the entire Coherus team in advancing the Company’s important mission.”
Since January 2018, Ms. Tzoumakas has served
8-K
EX-99.2
CHRS
Coherus Biosciences Inc
2 Feb 21
Entry into a Material Definitive Agreement
8:45am
BioSciences, Inc.
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have
8-K
EX-99.1
cu7a3f dx2itxi2q9
27 Feb 20
Coherus BioSciences Reports Fourth Quarter and Full Year 2019 Financial Results
4:16pm
8-K
EX-99.1
i1a74h xnxuvba7hy
5 Nov 20
Coherus BioSciences Reports Third Quarter 2020 Financial Results
4:07pm
8-K
EX-99.1
3qtle8ob hok
9 May 24
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
4:17pm
8-K
EX-99.1
hb2j1n 48ij
24 Feb 21
Coherus BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results
4:05pm
8-K
EX-99.1
ftlbvckcd
5 Aug 21
Coherus BioSciences Reports Second Quarter 2021 Financial Results and Immuno-oncology and Biosimilar Pipeline Progress
4:06pm
8-K
EX-99.1
v4ob74t
8 Nov 21
Coherus BioSciences Reports Third Quarter 2021 Results
4:06pm
8-K
EX-99.1
gbyf4a mdjg05u4
6 May 21
Coherus BioSciences Reports First Quarter 2021 Financial Results and Immuno-oncology and Biosimilar Pipeline Progress
4:24pm
8-K
EX-99.1
tqmdrse8
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
8-K
EX-99.1
cnzwjce99
27 Oct 23
Regulation FD Disclosure
4:19pm